Synektik SA
WSE:SNT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
KKR & Co Inc
SWB:KR51
|
US |
|
All for One Group SE
XETRA:A1OS
|
DE |
|
Dutch Bros Inc
NYSE:BROS
|
US |
|
D
|
DKK Co Ltd
TSE:6706
|
JP |
Synektik SA
Research & Development
Synektik SA
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Synektik SA
WSE:SNT
|
Research & Development
-zł3.3m
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
M
|
Medapp SA
WSE:MDA
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Synektik SA
Glance View
Synektik SA provides medical and information technology solutions. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 145 full-time employees. The company went IPO on 2011-08-09. The company produces PACS software which allows running a diagnostic imaging laboratory. The company runs a research laboratory which performs acceptance and specialist tests of X-ray equipment. The firm sells medical equipment and operates a services center for imaging equipment. Synektik SA is a partner of Siemens. On November 28, 2013, the Company raised its stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o to 100%.
See Also
What is Synektik SA's Research & Development?
Research & Development
-3.3m
PLN
Based on the financial report for Sep 30, 2025, Synektik SA's Research & Development amounts to -3.3m PLN.
What is Synektik SA's Research & Development growth rate?
Research & Development CAGR 3Y
31%
Over the last year, the Research & Development growth was 86%. The average annual Research & Development growth rates for Synektik SA have been 31% over the past three years .
